Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Abzena has announced a $10M investment of growth capital from Biospring Partners, a New York based investment firm.
read more
La Loma, Tlalnepantla, Mexico, Real Clean Distribuciones SA de CV is voluntarily recalling all lots four hand sanitizers it manufactured.
read more
Sandoz has announced plans for a joint investment, together with the Austrian federal government, to strengthen the long-term future of integrated antibiotics manufacturing in Europe.
read more
Elligo Health Research is proud to welcome Michael Gibertini, Ph.D., to its leadership team.
read more
PCI announced a milestone in its global clinical footprint with the creation of a new Clinical COE in Western Europe at its Berlin location.
read more
Avid Bioservices and Argonaut announced an to provide clients an integrated manufacturing solution including process development, drug substance manufacturing, and drug product manufacturing.
read more
Avacta announced an expansion of its collaboration and license agreement with Daewoong and AffyXell Therapeutics.
read more
IVD devices are tests performed on samples taken from the human body, such as swabs of mucus from inside the nose or back of the throat, or blood taken from a vein or fingerstick.
read more
Piramal is providing Bolt with the supply of both the BDC-1001 ISAC drug substance and the drug product for Bolt's ongoing Phase 1/2 clinical study in cancer patients.
read more
Intravacc and Celonic have signed a research agreement to further design, develop and produce a Covid-19 vaccine.
read more
InveniAI® has announced a strategic collaboration with GlaxoSmithKline Consumer Healthcare.
read more
Strata has signed an agreement with BioMed to accelerate patient identification and enrollment for BioMed Valley's Phase 2 study of BVD-523 for advanced malignancies harboring MEK or atypical BRAF alterations.
read more
Catalent will provide support for the development, manufacturing, and clinical supply of Editas Medicine’s current and future portfolio of in vivo CRISPR medicines and engineered cell medicines.
read more
Wednesday, August 05, 2020
The FDA proposed to include four bulk drug substances on the list of bulk drug substances that outsourcing facilities may use in drug compounding consistent with section 503B of the Federal Food, Drug & Cosmetic Act.
read more
Wednesday, August 05, 2020
Quest announced the FDA has granted EUA for a new laboratory technique that speeds the process of extracting viral RNA from specimens to expand its daily capacity of COVID-19 molecular diagnostic tests on behalf of patients.
read more